Search research articles
Contact Us
Filters
Showing results (91-100 of 230) with videos related to
Page
of 23
Sort By:
European Urology
|
May 29, 2013
Maintenance bacillus Calmette-Guérin treatment of non-muscle-invasive bladder cancer: a critical evaluation of the evidence
Behfar Ehdaie, Richard Sylvester, Harry W Herr
Urology
|
August 18, 2014
Clinical value of transurethral second resection of bladder tumor: systematic review
Jakub Dobruch, Andrzej Borówka, Harry W Herr
The Journal of Urology
|
February 11, 2003
Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy
Daniel W Lin, Harry W Herr, Guido Dalbagni
Urology
|
August 30, 2003
Presacral cystic schwannoma in a man
Sero Andonian, Pierre I Karakiewicz, Harry W Herr
Urologic Oncology
|
March 28, 2015
BCG-refractory vs. BCG-relapsing non-muscle-invasive bladder cancer: a prospective cohort outcomes study
Harry W Herr, Tanya N Milan, Guido Dalbagni
The Journal of Urology
|
March 27, 2007
Use of urinary biomarkers for bladder cancer surveillance: patient perspectives
Ofer Yossepowitch, Harry W Herr, S Machele Donat
BJU International
|
December 17, 2009
The effect of gender on response to bacillus Calmette-Guérin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder
Stephen A Boorjian, Fang Zhu, Harry W Herr
European Urology
|
April 19, 2011
Bacillus Calmette-Guérin without maintenance therapy for high-risk non-muscle-invasive bladder cancer
Harry W Herr, Guido Dalbagni, Sherri M Donat
Urology
|
November 14, 2002
Impact of a second transurethral resection on the staging of T1 bladder cancer
Guido Dalbagni, Harry W Herr, Victor E Reuter
The Journal of Urology
|
August 21, 2002
Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder
Harry W Herr, S Machele Donat, Guido Dalbagni
Page
of 23
Search research articles
Search
Showing results (91-100 of 230) with videos related to
Sort By:
Page
of 23
European Urology
|
May 29, 2013
Maintenance bacillus Calmette-Guérin treatment of non-muscle-invasive bladder cancer: a critical evaluation of the evidence
Behfar Ehdaie, Richard Sylvester, Harry W Herr
Urology
|
August 18, 2014
Clinical value of transurethral second resection of bladder tumor: systematic review
Jakub Dobruch, Andrzej Borówka, Harry W Herr
The Journal of Urology
|
February 11, 2003
Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy
Daniel W Lin, Harry W Herr, Guido Dalbagni
Urology
|
August 30, 2003
Presacral cystic schwannoma in a man
Sero Andonian, Pierre I Karakiewicz, Harry W Herr
Urologic Oncology
|
March 28, 2015
BCG-refractory vs. BCG-relapsing non-muscle-invasive bladder cancer: a prospective cohort outcomes study
Harry W Herr, Tanya N Milan, Guido Dalbagni
The Journal of Urology
|
March 27, 2007
Use of urinary biomarkers for bladder cancer surveillance: patient perspectives
Ofer Yossepowitch, Harry W Herr, S Machele Donat
BJU International
|
December 17, 2009
The effect of gender on response to bacillus Calmette-Guérin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder
Stephen A Boorjian, Fang Zhu, Harry W Herr
European Urology
|
April 19, 2011
Bacillus Calmette-Guérin without maintenance therapy for high-risk non-muscle-invasive bladder cancer
Harry W Herr, Guido Dalbagni, Sherri M Donat
Urology
|
November 14, 2002
Impact of a second transurethral resection on the staging of T1 bladder cancer
Guido Dalbagni, Harry W Herr, Victor E Reuter
The Journal of Urology
|
August 21, 2002
Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder
Harry W Herr, S Machele Donat, Guido Dalbagni
Page
of 23